Stock RVNC REVANCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Revance Therapeutics, Inc.

Equities

RVNC

US7613301099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
2.7 USD -6.90% Intraday chart for Revance Therapeutics, Inc. -4.93% -69.28%
May. 10 Needham Adjusts Price Target on Revance Therapeutics to $12 From $18, Maintains Buy Rating MT
May. 10 Piper Sandler Cuts Price Target on Revance Therapeutics to $11 From $20, Maintains Overweight Rating MT

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Revance Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
Transcript : Revance Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 09:30 AM
Transcript : Revance Therapeutics, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Transcript : Revance Therapeutics, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Transcript : Revance Therapeutics, Inc. - Analyst/Investor Day
Transcript : Revance Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023
Transcript : Revance Therapeutics, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 08:40 AM
Transcript : Revance Therapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023
Transcript : Revance Therapeutics, Inc. Presents at Barclays Global Healthcare Conference, Mar-14-2023 09:00 AM
Transcript : Revance Therapeutics, Inc., Q4 2022 Earnings Call, Feb 28, 2023
Transcript : Revance Therapeutics, Inc., Q3 2022 Earnings Call, Nov 08, 2022
Transcript : Revance Therapeutics, Inc. - Special Call
Transcript : Revance Therapeutics, Inc., Q2 2022 Earnings Call, Aug 09, 2022
Transcript : Revance Therapeutics, Inc., Q1 2022 Earnings Call, May 10, 2022
Transcript : Revance Therapeutics, Inc., Q4 2021 Earnings Call, Feb 28, 2022
Revance Therapeutics, Inc. Provides RHA® Collection Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2021
CI
Transcript : Revance Therapeutics, Inc., Q3 2021 Earnings Call, Nov 09, 2021
Transcript : Revance Therapeutics, Inc. Presents at Wells Fargo 2021 Virtual Healthcare Conference, Sep-09-2021 12:40 PM
Transcript : Revance Therapeutics, Inc., Q2 2021 Earnings Call, Aug 05, 2021
Transcript : Revance Therapeutics, Inc. Presents at Goldman Sachs 42nd Annual Global Healthcare Conference, Jun-08-2021 04:40 PM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RVNC Stock
  4. News Revance Therapeutics, Inc.
  5. Transcripts